View Clinical Trial (Medical Research Study)

Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy - NCT00699556-06519(Clinical Trial 226446)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  New Haven
State:  
CT
Zip Code: 06519
Conditions: Alcohol Drinking
Purpose: This study examines the effect of combined nicotine replacement therapy (transdermal patch + nasal spray vs. transdermal patch + placebo nasal spray) on reactivity to alcohol and self-administration behavior.
Study summary:
Criteria: Inclusion Criteria: - Ages 21 and over - Able to read and write in English - Smoker - Heavy drinker Exclusion Criteria: - Any significant current medical or psychiatric conditions that would contraindicate the consumption of alcohol or nicotine - Significant hepatocellular injury - Positive test result at intake appointments on urine drug screens conducted for opiates, cocaine, or benzodiazepines - Women who are pregnant or nursing - Suicidal, homicidal, or evidence of severe mental illness - Prescription of any psychotropic drug in the 30 days prior to study enrollment - Blood donation within the past 8 weeks - Individuals who are seeking treatment for drinking or smoking who have attempted to quit drinking or smoking within the past 3 months - Specific exclusions for administration of nicotine nasal spray not specified above including nasal polyps, chronic nasal congestion, allergies, sinusitis - Specific exclusions for administration of nicotine patch not specified above including history of dermatoses - Reported sensitivity or allergies to pepper or pepper spray, peppermint, or prior adverse reaction to nicotine spray - Participation within the past 8 weeks in other studies that involve additive blood sampling and/or interventional measures that would be considered excessive in combination with the current study
Study is available at: Connecticut Mental Health Center & Yale-New Haven Hospital
New Haven, CT 06519
United States

Primary Contact:
Sabrina Coppola
Phone: 203-737-2827
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 22, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.